Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Bio Capital Holdings LLC is currently overseeing 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. The prosecution for this portfolio is distributed across 3 distinct examiners. These matters are situated within 3 distinct art units, indicating that the company's technical innovations are being reviewed by several specialized groups. This variety of examiners and art units requires a coordinated strategy to maintain consistency across the patent office.
The busiest examiner for this portfolio is ZAHORIK, AMANDA MARY, who is responsible for 1 pending office action. As an examiner involved, ZAHORIK, AMANDA MARY serves as a point of contact for the applicant. For a patent practitioner, this environment requires managing relationships with the assigned personnel. The practitioner must tailor their responses to the expectations of the experts within the Biotechnology & Pharmaceuticals field. This structure involves administrative tracking of the 1 pending matter assigned to the busiest examiner while the total volume is 3 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINGH, ANOOP KUMAR | 1 | 43.2% | +67.7% |
| STOICA, ELLY GERALD | 1 | 66.8% | +22.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19013103 | GENELIGHT CULTURES AND EXTRACTS AND APPLICATIONS THEREOF | SINGH, ANOOP KUMAR | — |
| 19013121 | BIOLOGICAL DEVICES AND COMPOSITIONS FOR INCREASING HAIR GROWTH AND METHODS OF USE THEREOF | STOICA, ELLY GERALD | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19013103 | GENELIGHT CULTURES AND EXTRACTS AND APPLICATIONS THEREOF | SINGH, ANOOP KUMAR | 1632 | §103 | Final Rejection | — | Pending | Jan 08, 2025 |
| 19013121 | BIOLOGICAL DEVICES AND COMPOSITIONS FOR INCREASING HAIR GROWTH AND METHODS OF USE THEREOF | STOICA, ELLY GERALD | 1647 | §112 | Final Rejection | — | Pending | Jan 08, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBio Capital Holdings LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Anoop Kumar Singh has the most, with 1 of Bio Capital Holdings LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
